The Evolving Treatment Landscape of Renal Cell Carcinoma: Highlights from ESMO 2022 and Beyond : Episode 12
Systemic Therapy in the Treatment of Non-Clear Cell RCC: The Evolving Landscape
Moving on to discuss the management of non–clear cell renal cell carcinoma, panelists consider cornerstone treatment options in this setting.
EP: 1.Overview on Clear Cell Renal Cell Carcinoma: Prevalence and Prognosis
EP: 2.What is the Role of Nephrectomy in Advanced Clear Cell RCC?
EP: 3.Selecting the Appropriate First-Line Therapy in Advanced Clear Cell RCC
EP: 4.Advanced Clear Cell RCC: Role of Site of Metastases in Selecting First-Line Therapy
EP: 5.Treating Patients with Clear Cell RCC with Brain Metastases or Sarcomatoid Disease
EP: 6.Advanced Clear Cell RCC: Quality of Life Data in First-Line Clinical Trials
EP: 7.First-Line Therapy in Advanced Clear Cell RCC: Novel Doublet Regimens
EP: 8.First-Line Therapy in Advanced Clear Cell RCC: Novel Triplet Regimens
EP: 9.Is There a Role for Adjuvant Therapy in Advanced Clear Cell RCC?
EP: 10.Treatment Options for Advanced Clear Cell RCC in the Second-Line and Beyond
EP: 11.Advanced Clear Cell RCC: Optimal Selection and Sequencing of Second-Line Therapy
Now Viewing
EP: 12.Systemic Therapy in the Treatment of Non-Clear Cell RCC: The Evolving Landscape
EP: 13.Novel Treatment Strategies in Non-Clear Cell Renal Cell Carcinoma
EP: 14.Future Directions in the Management of Renal Cell Carcinoma
Related Videos
Related Content
